PreciThera is a biotechnology company committed to the development of therapies for rare bone diseases using the combined application of computational technology and a deep understanding of disease pathology. The Company focuses on heterogeneous genetic disorders that primarily manifest in bone dysfunction. In depth understanding of disease mechanism will allow PreciThera’s targeted strategies to meaningfully impact both the skeletal symptoms as well as the extraskeletal issues found in these patients.

Type
Private
HQ
Montréal, CA
Founded
2016
Size (employees)
4 (est)
PreciThera was founded in 2016 and is headquartered in Montréal, CA
Report incorrect company information

Key People/Management at PreciThera

Pierre Beauparlant

Pierre Beauparlant

CEO

PreciThera Office Locations

PreciThera has an office in Montréal
Montréal, CA (HQ)
408 1010 Rue Sherbrooke Ouest
Show all (1)
Report incorrect company information

PreciThera Financials and Metrics

Summary Metrics

Founding Date

2016

PreciThera total Funding

$28.7 m

PreciThera latest funding size

$28.74 m

Time since last funding

a year ago

PreciThera investors

PreciThera's latest funding round in July 2017 was reported to be $28.7 m. In total, PreciThera has raised $28.7 m
Show all financial metrics
Report incorrect company information

PreciThera Company Life and Culture

Report incorrect company information